ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Storytel Ab (publ)

Storytel Ab (publ) (0GBU)

104.80
0.00
(0.00%)
Closed January 05 11:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
104.80
Bid
99.80
Ask
109.80
Volume
80
0.00 Day's Range 0.00
104.80 52 Week Range 104.80
Market Cap
Previous Close
104.80
Open
-
Last Trade
80
@
66.55
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
444
Shares Outstanding
77,107,000
Dividend Yield
-
PE Ratio
-0.53
Earnings Per Share (EPS)
-10.62
Revenue
3.49B
Net Profit
-819.19M

About Storytel Ab (publ)

Sector
Offices-holdng Companies,nec
Industry
Plumb,heat & Air-condition
Headquarters
Stockholm, Swe
Founded
2009
Storytel Ab (publ) is listed in the Offices-holdng Companies sector of the London Stock Exchange with ticker 0GBU. The last closing price for Storytel Ab (publ) was SEK104.80. Over the last year, Storytel Ab (publ) shares have traded in a share price range of SEK 104.80 to SEK 104.80.

Storytel Ab (publ) currently has 77,107,000 shares outstanding. The market capitalization of Storytel Ab (publ) is SEK8.08 billion. Storytel Ab (publ) has a price to earnings ratio (PE ratio) of -0.53.

0GBU Latest News

Storytel enters strategic partnership with ElevenLabs and announces upcoming launch of new VoiceSwitcher feature

Storytel enters strategic partnership with ElevenLabs and announces upcoming launch of new VoiceSwitcher feature PR Newswire STOCKHOLM, June 13, 2023 STOCKHOLM, June 13, 2023 /PRNewswire/...

Storytel enters strategic partnership with ElevenLabs and announces upcoming launch of new VoiceSwitcher feature

Storytel enters strategic partnership with ElevenLabs and announces upcoming launch of new VoiceSwitcher feature PR Newswire STOCKHOLM, June 13, 2023 STOCKHOLM, June 13, 2023 /PRNewswire/...

Storytel presents mid-term financial targets and strategic direction to further strengthen its leading position

Storytel presents mid-term financial targets and strategic direction to further strengthen its leading position PR Newswire STOCKHOLM, June 13, 2023 STOCKHOLM, June 13, 2023 /PRNewswire/ -- At...

Storytel presents mid-term financial targets and strategic direction to further strengthen its leading position

Storytel presents mid-term financial targets and strategic direction to further strengthen its leading position PR Newswire STOCKHOLM, June 13, 2023 STOCKHOLM, June 13, 2023 /PRNewswire/ -- At...

Invitation to Storytel's Capital Markets Day 2023

Invitation to Storytel's Capital Markets Day 2023 PR Newswire STOCKHOLM, May 22, 2023 STOCKHOLM, May 22, 2023 /PRNewswire/ -- Storytel has the pleasure to invite investors, analysts and media to...

Storytel Group acquires the rights to the Finnish bestselling Koskinen crime series

Storytel Group acquires the rights to the Finnish bestselling Koskinen crime series PR Newswire STOCKHOLM, May 15, 2023 STOCKHOLM, May 15, 2023 /PRNewswire/ -- The Koskinen Crime series is a huge...

Storytel Interim Report January - March 2023

Storytel Interim Report January - March 2023 PR Newswire STOCKHOLM, May 3, 2023 STOCKHOLM, May 3, 2023 /PRNewswire/ -- "Laying the foundation for further profitable growth in 2023 and beyond...

New partnership with A1 Bulgaria brings Storytel's offering to 3.8 million Bulgarians

New partnership with A1 Bulgaria brings Storytel's offering to 3.8 million Bulgarians PR Newswire STOCKHOLM, April 25, 2023 STOCKHOLM, April 25, 2023 /PRNewswire/ -- Storytel, one of the world's...

Storytel and B-Reel shortlisted for the One Show and the Webby Awards

Storytel and B-Reel shortlisted for the One Show and the Webby Awards PR Newswire STOCKHOLM, April 14, 2023 STOCKHOLM, April 14, 2023 /PRNewswire/ -- The captivating Storytel campaign "2022...

Storytel and B-Reel shortlisted for the One Show and the Webby Awards

Storytel and B-Reel shortlisted for the One Show and the Webby Awards PR Newswire STOCKHOLM, April 14, 2023 STOCKHOLM, April 14, 2023 /PRNewswire/ -- The captivating Storytel campaign "2022...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100104.8104.8104.800DE
400104.8104.8104.8466104.8DE
1200104.8104.8104.8444104.8DE
2600104.8104.8104.82279104.8DE
5200104.8104.8104.81836104.8DE
15600104.8104.8104.812227104.8DE
26000104.8104.8104.87787104.8DE

0GBU - Frequently Asked Questions (FAQ)

What is the current Storytel Ab (publ) share price?
The current share price of Storytel Ab (publ) is SEK 104.80
How many Storytel Ab (publ) shares are in issue?
Storytel Ab (publ) has 77,107,000 shares in issue
What is the market cap of Storytel Ab (publ)?
The market capitalisation of Storytel Ab (publ) is SEK 8.08B
What is the 1 year trading range for Storytel Ab (publ) share price?
Storytel Ab (publ) has traded in the range of SEK 104.80 to SEK 104.80 during the past year
What is the PE ratio of Storytel Ab (publ)?
The price to earnings ratio of Storytel Ab (publ) is -0.53
What is the cash to sales ratio of Storytel Ab (publ)?
The cash to sales ratio of Storytel Ab (publ) is 0.13
What is the reporting currency for Storytel Ab (publ)?
Storytel Ab (publ) reports financial results in SEK
What is the latest annual turnover for Storytel Ab (publ)?
The latest annual turnover of Storytel Ab (publ) is SEK 3.49B
What is the latest annual profit for Storytel Ab (publ)?
The latest annual profit of Storytel Ab (publ) is SEK -819.19M
What is the registered address of Storytel Ab (publ)?
The registered address for Storytel Ab (publ) is TRYCKERIGATAN 4, STOCKHOLM, SE-104 51
What is the Storytel Ab (publ) website address?
The website address for Storytel Ab (publ) is www.massolitmedia.se
Which industry sector does Storytel Ab (publ) operate in?
Storytel Ab (publ) operates in the PLUMB,HEAT & AIR-CONDITION sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
BDEZ BDEZ 6 minutes ago
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 6 minutes ago
Not good, thanks for sharing.
sand sand 13 minutes ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 13 minutes ago
Moving hard soon 
EFSH
mining101 mining101 15 minutes ago
Superb
MEGL
benz280c benz280c 22 minutes ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 29 minutes ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 29 minutes ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 33 minutes ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 38 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 39 minutes ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 43 minutes ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 46 minutes ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 46 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 49 minutes ago
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 52 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 54 minutes ago
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 55 minutes ago
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO
Pickme2 Pickme2 56 minutes ago
Stop wasting our time with your ongoing Manipulated nonsense.... Just read the S-1 
Filed with the sec.... 


ATMH
georgejjl georgejjl 57 minutes ago
The MABs are no where near being the standard of care for treating Alzheimer’s patients.
AVXL
benz280c benz280c 59 minutes ago
Phone died when responding to that. In summary, I think the 24/7 is multi-pronged. It is necessary for the kind of business that Veemost is and will be, which aligns it and will help it qualify for Gold. I do not recall it expressly said that Gold was reached and turned down. Not saying that didn't
GDVM
Sheepdog Sheepdog 1 hour ago
Really? So you think the SEC is going to start arresting OTC Scammers and Pump/Dumpers? I hope so...about time.
GCAN
Hummingbird2 Hummingbird2 1 hour ago
$GTII ~ Just listen in the first 5 mins about $GTII 🛫 after March? https://www.youtube.com/watch?v=Ag2f2rDlq5g
GTII